Global Gastrointestinal Drugs Competitive Landscape Professional Research Report 2024

Global Gastrointestinal Drugs Competitive Landscape Professional Research Report 2024



Research Summary

Gastrointestinal (GI) drugs are medications designed to treat disorders and diseases affecting the digestive system, which includes the stomach, intestines, and associated organs. These drugs address a wide range of conditions such as acid reflux, peptic ulcers, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), constipation, diarrhea, and nausea. Common classes of GI drugs include antacids, proton pump inhibitors (PPIs), H2-receptor antagonists, laxatives, antidiarrheals, antiemetics, and antispasmodics. For instance, antacids and PPIs are used to reduce stomach acid and relieve symptoms of heartburn and acid reflux, while laxatives help alleviate constipation by promoting bowel movements. These medications can be available over-the-counter or by prescription, depending on their strength and specific use. Gastrointestinal drugs play a crucial role in improving the quality of life for patients by managing symptoms, promoting healing, and preventing complications associated with GI disorders.

According to DIResearch's in-depth investigation and research, the global Gastrointestinal Drugs market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Gastrointestinal Drugs include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria (Tillotts), Perrigo, Boehringer Ingelheim, Purdue Pharma, C.B. Fleet, Abbott, Jiangzhong, Xian-Janssen etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Gastrointestinal Drugs. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gastrointestinal Drugs market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gastrointestinal Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gastrointestinal Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Gastrointestinal Drugs Include:

AstraZeneca

Sanofi

Bayer

Pfizer

GlaxoSmithKline

Teva

Zeria (Tillotts)

Perrigo

Boehringer Ingelheim

Purdue Pharma

C.B. Fleet

Abbott

Jiangzhong

Xian-Janssen

Gastrointestinal Drugs Product Segment Include:

Prescription Gastrointestinal Drug

OTC Gastrointestinal Drug

Gastrointestinal Drugs Product Application Include:

Chronic Gastritis

Functional Dyspepsia

Peptic Ulcer

Acute Gastroenteritis

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Gastrointestinal Drugs Industry PESTEL Analysis

Chapter 3: Global Gastrointestinal Drugs Industry Porter’s Five Forces Analysis

Chapter 4: Global Gastrointestinal Drugs Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Gastrointestinal Drugs Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Gastrointestinal Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Gastrointestinal Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Gastrointestinal Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Gastrointestinal Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Gastrointestinal Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Gastrointestinal Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Gastrointestinal Drugs Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Gastrointestinal Drugs Market Overview
1.1 Product Definition and Statistical Scope
1.2 Gastrointestinal Drugs Product by Type
1.2.1 Global Gastrointestinal Drugs Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Gastrointestinal Drugs Product by Application
1.3.1 Global Gastrointestinal Drugs Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Other
1.4 Global Gastrointestinal Drugs Market Revenue and Sales Analysis
1.4.1 Global Gastrointestinal Drugs Market Size Analysis (2019-2030)
1.4.2 Global Gastrointestinal Drugs Market Sales Analysis (2019-2030)
1.4.3 Global Gastrointestinal Drugs Market Sales Price Trend Analysis (2019-2030)
1.5 Gastrointestinal Drugs Market Development Status and Trends
1.5.1 Gastrointestinal Drugs Industry Development Status Analysis
1.5.2 Gastrointestinal Drugs Industry Development Trends Analysis
2 Gastrointestinal Drugs Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Gastrointestinal Drugs Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Gastrointestinal Drugs Market Analysis by Regions
4.1 Gastrointestinal Drugs Overall Market: 2023 VS 2024 VS 2030
4.2 Global Gastrointestinal Drugs Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Gastrointestinal Drugs Revenue and Market Share by Region (2019-2024)
4.2.2 Global Gastrointestinal Drugs Revenue Forecast by Region (2025-2030)
4.3 Global Gastrointestinal Drugs Sales and Forecast Analysis (2019-2030)
4.3.1 Global Gastrointestinal Drugs Sales and Market Share by Region (2019-2024)
4.3.2 Global Gastrointestinal Drugs Sales Forecast by Region (2025-2030)
4.4 Global Gastrointestinal Drugs Sales Price Trend Analysis (2019-2030)
5 Global Gastrointestinal Drugs Market Size by Type and Application
5.1 Global Gastrointestinal Drugs Market Size by Type
5.1.1 Global Gastrointestinal Drugs Revenue and Forecast Analysis by Type (2019-2030)
5.1.2 Global Gastrointestinal Drugs Sales and Forecast Analysis by Type (2019-2030)
5.2 Global Gastrointestinal Drugs Market Size by Application
5.2.1 Global Gastrointestinal Drugs Revenue and Forecast Analysis by Application (2019-2030)
5.2.2 Global Gastrointestinal Drugs Sales and Forecast Analysis by Application (2019-2030)
6 North America
6.1 North America Gastrointestinal Drugs Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Gastrointestinal Drugs Market Size by Type
6.3.1 North America Gastrointestinal Drugs Sales by Type (2019-2030)
6.3.2 North America Gastrointestinal Drugs Revenue by Type (2019-2030)
6.4 North America Gastrointestinal Drugs Market Size by Application
6.4.1 North America Gastrointestinal Drugs Sales by Application (2019-2030)
6.4.2 North America Gastrointestinal Drugs Revenue by Application (2019-2030)
6.5 North America Gastrointestinal Drugs Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Gastrointestinal Drugs Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Gastrointestinal Drugs Market Size by Type
7.3.1 Europe Gastrointestinal Drugs Sales by Type (2019-2030)
7.3.2 Europe Gastrointestinal Drugs Revenue by Type (2019-2030)
7.4 Europe Gastrointestinal Drugs Market Size by Application
7.4.1 Europe Gastrointestinal Drugs Sales by Application (2019-2030)
7.4.2  Europe Gastrointestinal Drugs Revenue by Application (2019-2030)
7.5 Europe Gastrointestinal Drugs Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Gastrointestinal Drugs Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Gastrointestinal Drugs Market Size by Type
8.3.1 China Gastrointestinal Drugs Sales by Type (2019-2030)
8.3.2 China Gastrointestinal Drugs Revenue by Type (2019-2030)
8.4 China Gastrointestinal Drugs Market Size by Application
8.4.1 China Gastrointestinal Drugs Sales by Application (2019-2030)
8.4.2 China Gastrointestinal Drugs Revenue by Application (2019-2030)
9 APAC (excl. China)
9.1 APAC (excl. China) Gastrointestinal Drugs Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Gastrointestinal Drugs Market Size by Type
9.3.1 APAC (excl. China) Gastrointestinal Drugs Sales by Type (2019-2030)
9.3.2 APAC (excl. China) Gastrointestinal Drugs Revenue by Type (2019-2030)
9.4 APAC (excl. China) Gastrointestinal Drugs Market Size by Application
9.4.1 APAC (excl. China) Gastrointestinal Drugs Sales by Application (2019-2030)
9.4.2 APAC (excl. China) Gastrointestinal Drugs Revenue by Application (2019-2030)
9.5 APAC (excl. China) Gastrointestinal Drugs Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Gastrointestinal Drugs Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Gastrointestinal Drugs Market Size by Type
10.3.1 Latin America Gastrointestinal Drugs Sales by Type (2019-2030)
10.3.2 Latin America Gastrointestinal Drugs Revenue by Type (2019-2030)
10.4 Latin America Gastrointestinal Drugs Market Size by Application
10.4.1 Latin America Gastrointestinal Drugs Sales by Application (2019-2030)
10.4.2 Latin America Gastrointestinal Drugs Revenue by Application (2019-2030)
10.5 Latin America Gastrointestinal Drugs Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Gastrointestinal Drugs Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Gastrointestinal Drugs Market Size by Type
11.3.1 Middle East & Africa Gastrointestinal Drugs Sales by Type (2019-2030)
11.3.2 Middle East & Africa Gastrointestinal Drugs Revenue by Type (2019-2030)
11.4 Middle East & Africa Gastrointestinal Drugs Market Size by Application
11.4.1 Middle East & Africa Gastrointestinal Drugs Sales by Application (2019-2030)
11.4.2 Middle East & Africa Gastrointestinal Drugs Revenue by Application (2019-2030)
11.5 Middle East & Africa Gastrointestinal Drugs Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Gastrointestinal Drugs Market Sales, Revenue and Price by Key Manufacturers (2020-2024)
12.1.1 Global Gastrointestinal Drugs Market Sales by Key Manufacturers (2020-2024)
12.1.2 Global Gastrointestinal Drugs Market Revenue by Key Manufacturers (2020-2024)
12.1.3 Global Gastrointestinal Drugs Average Sales Price by Manufacturers (2020-2024)
12.2 Gastrointestinal Drugs Competitive Landscape Analysis and Market Dynamic
12.2.1 Gastrointestinal Drugs Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 AstraZeneca
13.1.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 AstraZeneca Gastrointestinal Drugs Product Portfolio
13.1.3 AstraZeneca Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.2 Sanofi
13.2.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Sanofi Gastrointestinal Drugs Product Portfolio
13.2.3 Sanofi Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.3 Bayer
13.3.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Bayer Gastrointestinal Drugs Product Portfolio
13.3.3 Bayer Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.4 Pfizer
13.4.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Pfizer Gastrointestinal Drugs Product Portfolio
13.4.3 Pfizer Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 GlaxoSmithKline Gastrointestinal Drugs Product Portfolio
13.5.3 GlaxoSmithKline Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.6 Teva
13.6.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Teva Gastrointestinal Drugs Product Portfolio
13.6.3 Teva Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.7 Zeria (Tillotts)
13.7.1 Zeria (Tillotts) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Zeria (Tillotts) Gastrointestinal Drugs Product Portfolio
13.7.3 Zeria (Tillotts) Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.8 Perrigo
13.8.1 Perrigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Perrigo Gastrointestinal Drugs Product Portfolio
13.8.3 Perrigo Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Boehringer Ingelheim Gastrointestinal Drugs Product Portfolio
13.9.3 Boehringer Ingelheim Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.10 Purdue Pharma
13.10.1 Purdue Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Purdue Pharma Gastrointestinal Drugs Product Portfolio
13.10.3 Purdue Pharma Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.11 C.B. Fleet
13.11.1 C.B. Fleet Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 C.B. Fleet Gastrointestinal Drugs Product Portfolio
13.11.3 C.B. Fleet Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.12 Abbott
13.12.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 Abbott Gastrointestinal Drugs Product Portfolio
13.12.3 Abbott Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.13 Jiangzhong
13.13.1 Jiangzhong Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 Jiangzhong Gastrointestinal Drugs Product Portfolio
13.13.3 Jiangzhong Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.14 Xian-Janssen
13.14.1 Xian-Janssen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 Xian-Janssen Gastrointestinal Drugs Product Portfolio
13.14.3 Xian-Janssen Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Gastrointestinal Drugs Industry Chain Analysis
14.2 Gastrointestinal Drugs Industry Upstream Supply Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Gastrointestinal Drugs Typical Downstream Customers
14.4 Gastrointestinal Drugs Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings